Your session is about to expire
← Back to Search
Speed Manipulated Adaptive Rehabilitation Therapy Bike for Parkinson's Disease (SMART Trial)
SMART Trial Summary
This trial will investigate how patient-specific settings for high-cadence cycling can improve functional performance in individuals with Parkinson's disease.
SMART Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSMART Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SMART Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with Parkinson's disease.I have major heart or lung disease symptoms.I am between 50 and 79 years old.
- Group 1: Adaptive dynamic cycling
- Group 2: Non-adaptive dynamic cycling
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for enrolment in this experiment?
"Affirmative. According to the information found on clinicaltrials.gov, this medical experiment is currently enrolling participants; it was initially posted on April 11th 2022 and recently revised on May 3rd 2022. Forty patients are necessary for the study which is being conducted at one site only."
Does this research encompass participants aged 30 or older?
"As stipulated in the criteria for admittance, this trial only accepts patients between 50 and 79 years of age."
How many participants is the trial accommodating?
"Correct. According to clinicaltrials.gov, this medical research project is actively searching for 40 participants from one site; the listing was posted on April 11th 2022 and updated May 3rd 2022."
Is it possible for me to become a participant in this clinical experiment?
"The present clinical trial is accepting a cohort of 40 elderly patients, aged between 50 and 79, who suffer from idiopathic Parkinson's disease. Preceding admission to the study, it must be confirmed that there are no contraindications for exercise due to cardiovascular disease or stroke."
Share this study with friends
Copy Link
Messenger